Delivery Order SPE2DB20D3103-SPE2DB24FP4R1

Award Date 7/9/24
Potential Completion Date 7/10/24
Potential Value $3.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,294.96 firm fixed-price delivery order is for the supply of CINACALCET HCL 30 MG TABLET 30S, a medication used to treat certain types of hyperparathyroidism. The contract has an ultimate completion date of November 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,524.40 firm fixed-price delivery order is for 4,567,394,905 units of CINACALCET HCL 30 MG TABLET 30S. The contract has a ceiling value of $5,524.40 and a completion date of February 27, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,522.07 firm fixed-price delivery order is for the supply of 4,560,425,714 units of the drug Cinacalcet HCl 30 mg tablets. The contract has an ultimate completion date of March 30, 2023 and was awarded on March 29, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,047.36 fixed-price contract is for the delivery of Cinacalcet HCl 30 mg tablets, with a period of performance running through October 17, 2024. The contract is not designated as a set-aside and represents an open competition. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,774.92 firm fixed-price delivery order is for the supply of Cinacalcet HCl 30 mg tablets. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Cinacalcet HCl 30 mg tablets. The contract, valued at $1,563.18, is a firm fixed-price delivery order without any set-aside designation, indicating open competition. The contract has an ultimate completion date of October 16, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,878.75, is a Firm Fixed Price Delivery Order for the supply of Cinacalcet HCl 30 mg tablets. The contract has a period of performance through July 3, 2024 and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,411.44 and an ultimate completion date of February 19, 2025. It covers the procurement of Cinacalcet HCl 30 mg tablets for federal government medical programs. AmerisourceBergen is an established vendor for the DLA, holding a $999,999,999 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 30 mg Cinacalcet HCl tablets, a medication used to treat certain types of kidney disease. The contract has a ceiling value of $24,719.33 and runs through March 14, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This federal contract award, with an ID of SPE2DB22D1017|SPE2DB25FE7FY, is for the delivery of 4,566,108,654 units of Cinacalcet HCl 30 mg tablets. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 15, 2024, with a ceiling value of $7,727.18. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of October 16, 2024. The contract was awarded by the Defense Logistics Agency (DLA), a defense...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FP4R1
    Delivery Order

This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,768.88 firm fixed-price delivery order is for the supply of CINACALCET HCL 30 MG TABLET UD 20S, a specialty medication. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. As a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems, Amerisourcebergen plays a critical role in supplying essential medical products to government agencies.

Generated 5/17/25, 9:50 AM